Shandong Sinoglory Health (603182) — Capital Reinvestment Ratio
Latest as of December 2025:
0.69x
Shandong Sinoglory Health (603182) has a Capital Reinvestment Ratio of 0.69x as of December 2025, meaning it reinvests 1% of its operating cash flow (CN¥79.36 Million) in capital expenditures (CN¥54.75 Million). See cash generation quality of Shandong Sinoglory Health to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.69x
Capex / Operating Cash Flow
Operating Cash Flow
CN¥79.36 Million
CNY
Capital Expenditures
CN¥54.75 Million
CNY
Data as of
Dec 2025
Most recent filing
Shandong Sinoglory Health Capital Reinvestment Ratio (2020–2025)
This chart tracks Shandong Sinoglory Health's Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Shandong Sinoglory Health (2020–2025)
Year-by-year Capital Reinvestment Ratio for Shandong Sinoglory Health from 2020 to 2025. For live market cap and broader valuation context, see 603182 stock market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.69x | CN¥79.36 Million | CN¥54.75 Million | ▼ -45.8% |
| 2024 | 1.27x | CN¥313.81 Million | CN¥399.54 Million | ▼ -69.3% |
| 2023 | 4.15x | CN¥37.34 Million | CN¥154.79 Million | ▲ +899.3% |
| 2022 | 0.41x | CN¥109.17 Million | CN¥45.29 Million | ▼ -46.6% |
| 2021 | 0.78x | CN¥43.34 Million | CN¥33.70 Million | ▲ +20.0% |
| 2020 | 0.65x | CN¥109.73 Million | CN¥71.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow